NeoGenomics (NEO) Stock News
$NEO · NASDAQ · HEALTHCARE · 4 stories in 30 daysBORSA has published 4 stories on NeoGenomics (NEO) in the past 30 days. BORSA’s news read on NEO is bullish at 65/100, −1 over 24 hours, based on 1 company event over the past 7 days. NEO last closed at $16.88 on Oct 14, up 5.70% over five sessions and down 10.64% over the past month. NeoGenomics’ next earnings report is scheduled for Tuesday, Oct 27.
The wire on $NEO
newest first · updated · direct subject stories onlyNeoGenomics (NEO) expanded its partnership with Indica Labs to deploy the HALO AP digital pathology platform across its enterprise. The cloud-based, vendor-neutral system is intended to reduce integration costs and capital investment while enabling third-party or in-house AI tools. The company expects the infrastructure to support AI-based biomarker testing as the ADC pipeline grows, and to enable future AI co-development and clinical trial collaborations. NeoGenomics has worked with Indica Labs since 2015.
bullish 70 · impact 40
